ClinicalTrials.govpublic full text
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
kawasaki disease, firsekibart, coronary artery lesion, ivig-resistant, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852887
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.